SkinBioTherapeutics Announces Director Dealings
Why we think this is neutral
This RNS announcement is a Director Dealings update, which does not fall under the mandatory news types specified. As a result, I have assigned a neutral sentiment score.
Key Points
- University of Manchester reduces stake in SkinBioTherapeutics from 3.42% to 2.93%
Summary
The healthcare company has announced changes to its major shareholdings.
SkinBioTherapeutics PLC has released a notification of major holdings, indicating that the University of Manchester has reduced its stake in the company from 3.42% to 2.93%.
DIRECTOR DEALINGS